Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells

Molecular Medicine

Volumn 14, Issue 11-12, 2008, Pages 675-681

  Zhang, Jie ^a   Jacobi, Annett M ^a   Wang, Tao ^a   Diamond, Betty ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G; PROTEIN AUTOANTIBODY A9; PROTEIN AUTOANTIBODY B5; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL ACTIVATION; CONTROLLED STUDY; DNA BINDING; GLOMERULUS; HUMAN; MEMORY CELL; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN ISOLATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; B-LYMPHOCYTES; CELL LINE; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN M; KIDNEY GLOMERULUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR SEQUENCE DATA; PROTEIN BINDING;

EID: 55749095746     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2008-00066.Zhang     Document Type: Article

References (26)

1. Tan EM. (1991) Autoantibodies in pathology and cell biology. Cell 67:841-2.
2. Renaudineau Y, et al. (2006) Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum. 54:2523-32.
3. Vlahakos D, et al. (1992) Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J. Am. Soc. Nephrol. 2:1345-54.
4. Vlahakos DV, et al. (1992) Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 41:1690-700.
5. Winfield JB, Faiferman I, Koffler D. (1977) Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. J. Clin. Invest. 59:90-6.
6. Radic MZ, et al. (1993) Residues that mediate DNA binding of autoimmune antibodies. J. Immunol. 150:4966-77.
7. Lambrianides A, et al. (2007) Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome. Arthritis Rheum. 56:2392-401.
8. Rahman A, et al. (2001) The importance of somatic mutations in the V(lambda) gene 2a2 in human monoclonal anti-DNA antibodies. J. Mol. Biol. 307:149-60.
9. Wellmann U, et al. (2005) The evolution of human anti-double-stranded DNA autoantibodies. Proc. Natl. Acad. Sci. U. S. A. 102:9258-63.
10. Yurasov S, et al. (2005) Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201:703-11.
11. Bernasconi NL, Traggiai E, Lanzavecchia A. (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-202.
12. Wehr C, et al. (2004) A new CD21low B cell population in the peripheral blood of patients with SLE. Clin. Immunol. 113:161-71.
13. Briere F, Servet-Delprat C, Bridon JM, Saint-Remy JM, Banchereau J. (1994) Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J. Exp. Med. 179:757-62.
14. Litinskiy MB, et al. (2002) DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:822-9.
15. Pene J, et al. (2004) Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172:5154-7.
16. Rahman A, Giles I, Haley J, Isenberg D. (2002) Systematic analysis of sequences of anti-DNA antibodies - relevance to theories of origin and pathogenicity. Lupus 11:807-23.
17. Hochberg MC. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:1725.
18. Zhang J, et al. (2008) Identification of DNA-reactive B cells in patients with systemic lupus erythematosus [technical note]. J. Immunol. Methods. 338:79-84.
19. Wardemann H, et al. (2003) Predominant autoantibody production by early human B cell precursors. Science 301:1374-7.
20. Zhao Z, et al. (2005) Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Arthritis Rheum. 52:522-30.
21. Seal SN, Monestier M, Radic MZ. (2000) Diverse roles for the third complementarity determining region of the heavy chain (H3) in the binding of immunoglobulin Fv fragments to DNA, nucleosomes and cardiolipin. Eur. J. Immunol. 30:3432-40.
22. Tsuiji M, et al. (2006) A checkpoint for autoreactivity in human IgM+ memory B cell development. J. Exp. Med. 203:393-400.
23. Pankewycz OG, Migliorini P, Madaio MP. (1987) Polyreactive autoantibodies are nephritogenic in murine lupus nephritis. J. Immunol. 139:3287-94.
24. Xie C, Liang Z, Chang S, Mohan C. (2003) Use of a novel elution regimen reveals the dominance of polyreactive antinuclear autoantibodies in lupus kidneys. Arthritis Rheum. 48:2343-52.
25. Ibrahim SM, Weigert M, Basu C, Erikson J, Radic MZ. (1995) Light chain contribution to specificity in anti-DNA antibodies. J. Immunol. 155:3223-33.
26. Radic MZ, Mascelli MA, Erikson J, Shan H, Weigert M. (1991) Ig H and L chain contributions to autoimmune specificities. J. Immunol. 146:176-82.